Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial
A program that got caught up in HHS’ decision to abandon mRNA research was revived by a public-private coalition and is now beginning a large, late-stage test that could support a future approval.
ORIGINAL SOURCE →via Biopharma Dive
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · health
- [HEALTH] Knowledge, Attitudes, and Practices Regarding Arboviruses at a Human-Wildlife Interface: A Cross-Sectional Study in and
- [HEALTH] Trk1 potassium transport is crucial for effective Candidozyma auris skin colonization.
- [HEALTH] [A rapid visual detection method for porcine circovirus type 4 based on enzymatic recombinase amplification and CRISPR/E
- [HEALTH] How the adult brain reuses an embryonic signal to balance persistence and change
- [HEALTH] ‘No cause for alarm’ – NCDC says on COVID-19 case in Cross River
- [HEALTH] Padres find rotation help, sign free agent Giolito